NexgenRx, Inc. announced the appointment of Mr. Barry J. Reiter as a director of the corporation. Barry Reiter is a partner with the law firm Bennett Jones LLP. Current board roles include: Syncapse Corp., HUB International (Advisory Board), and the Executive Committee of the Institute of Corporate Directors (Ontario Chapter).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.28 CAD | -3.45% | -3.45% | +27.27% |
17/05 | NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/05 | Charles Burns Tenders Resignation as Director of NexgenRx Inc | CI |
1st Jan change | Capi. | |
---|---|---|
+27.27% | 1.44Cr | |
-5.23% | 11TCr | |
+4.87% | 9.69TCr | |
+24.34% | 6.59TCr | |
+5.81% | 6.34TCr | |
+11.47% | 4.34TCr | |
+11.59% | 4.21TCr | |
+26.19% | 3.72TCr | |
+6.70% | 2.57TCr | |
-8.46% | 2.14TCr |
- Stock Market
- Equities
- NXG Stock
- News NexgenRx Inc.
- NexgenRx, Inc. Appoints Barry J. Reiter as New Board Member